Komori
CellSource (4880) · RiskRestated

Laws and Regulations Governing Cosmetics Sales and Product Liability

First written in FY2019. 3 of 4 entries say "Restated". Latest entry: FY2022.

4entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2019 – FY20222020: 120202021: 120212022: 120222023: 1
Same theme, other companies

The whole theme swung hardest in 2021: 2 of 11 companies on the "Worse" side.

15 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 19 companies compared. The sentences above are computed from all 19.
Full recordFilings, disclosures and news, newest first
  1. FY2022RestatedAnnual report

    「In addition, the operations conducted in the cosmetics sales business are subject to the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices with respect to the purchase and sale of cosmetics, and the Product Liability Act with respect to the manufacture and sale of our products」

    Risks relating to regulations, product liability, labeling and consumer protection in cosmetics sales remain.
  2. FY2021RestatedAnnual report

    「Our contract processing services and sales of medical devices are subject to laws and regulations including the Act on Ensuring Safety of Regenerative Medicine, the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices, the Product Liability Act, and the Waste Management and Public Cleansing Act.」

    Regulatory and product liability risks relating to regenerative medicine, medical devices and cosmetics sales remain.
  3. FY2020RestatedAnnual report

    「If we become subject to administrative sanctions, such as a business suspension order or surcharge, for violating these laws and regulations, or if we are unable to maintain the relevant licenses, or if we incur liability for damages under the Product Liability Act or other laws」

    Regulatory risks relating to advertising claims, consumer protection, personal information and product liability in cosmetics sales were reiterated.
  4. FY2019First statedAnnual report

    「If we become subject to administrative sanctions, such as a business suspension order or surcharge, for violating these laws and regulations, or if we are unable to maintain the relevant licenses, or if we incur liability for damages under the Product Liability Act or other laws」

    The company identifies multiple regulations affecting the consumer business as risks, including advertising claims, consumer protection, personal information and product liability.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for CellSource yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Laws and Regulations Governing Cosmetics Sales and Product Liability | CellSource Co.,Ltd. (4880) | Komori